Literature DB >> 2223245

Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness.

S Kliks1.   

Abstract

Antibody-dependent enhancement of certain virus infections can occur in cells expressing Fc receptors. This mechanism plays an important pathogenetic role in the development of complications associated with dengue virus infection, including dengue hemorrhagic infection and dengue shock syndrome. The virulence of the virus, characterized by the ability to infect Fc receptor-bearing monocytes also influences the development of these severe illnesses.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2223245     DOI： 10.1089/aid.1990.6.993

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


  25 in total

1.  Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys.

Authors:  N M Ferguson; C A Donnelly; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

2.  Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response.

Authors:  R G van Der Most; K Murali-Krishna; R Ahmed; J H Strauss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Infection of human cells by dengue virus is modulated by different cell types and viral strains.

Authors:  M S Diamond; D Edgil; T G Roberts; B Lu; E Harris
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  A three-component biomarker panel for prediction of dengue hemorrhagic fever.

Authors:  Allan R Brasier; Hyunsu Ju; Josefina Garcia; Heidi M Spratt; Sundar S Victor; Brett M Forshey; Eric S Halsey; Guillermo Comach; Gloria Sierra; Patrick J Blair; Claudio Rocha; Amy C Morrison; Thomas W Scott; Isabel Bazan; Tadeusz J Kochel
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

5.  Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner.

Authors:  Erin Mehlhop; Camilo Ansarah-Sobrinho; Syd Johnson; Michael Engle; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

6.  Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in mice.

Authors:  Kanakatte Raviprakash; Peifang Sun; Yossef Raviv; Thomas Luke; Nicholas Martin; Tadeusz Kochel
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

Review 7.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

8.  Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus.

Authors:  J S Salas-Benito; R M del Angel
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

9.  A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits.

Authors:  Kanakatte Raviprakash; Thomas Luke; John Doukas; Janine Danko; Kevin Porter; Timothy Burgess; Tadeusz Kochel
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

Review 10.  Type I and type II Fc receptors regulate innate and adaptive immunity.

Authors:  Andrew Pincetic; Stylianos Bournazos; David J DiLillo; Jad Maamary; Taia T Wang; Rony Dahan; Benjamin-Maximillian Fiebiger; Jeffrey V Ravetch
Journal:  Nat Immunol       Date:  2014-08       Impact factor: 25.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.